Cite
HARVARD Citation
Yap, J. et al. (n.d.). P194 Epivin: a phase II double-blind randomised control trial investigating the use of epigallocatechin-3-gallate (veregen®, catephen®) vs placebo in the treatment of usual-typed vulval intraepithelial neoplasia. International journal of gynecological cancer. p. A173. [Online].